Symbol: |
CYP2A6
|
Description: |
cytochrome P450, family 2, subfamily A, polypeptide 6 [Source:HGNC Symbol;Acc:2610]
|
Location: |
Chr19:41349444-41356352[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:151
Gene |
Compound |
Gen_sig |
Exp_pattern |
CYP2A6 |
NSC 408470 |
0.032 |
Down |
CYP2A6 |
9,10-o-Benzenoanthracene-1,4-dione, 2,3-dichloro-9,10-dihydro- |
0.049 |
Up |
CYP2A6 |
NSC 49713 |
0.001 |
Up |
CYP2A6 |
C.I. 37559 |
0.003 |
Up |
CYP2A6 |
NSC 58903 |
0.027 |
Up |
CYP2A6 |
Imidazole, 1-(4-chlorophenyl)-4-(4-nitrophenyl)- |
0.004 |
Up |
CYP2A6 |
4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride |
0.036 |
Up |
CYP2A6 |
Benzo[1,2-c:4,5-c']dipyrrole-1,3,5,7(2H,6H)-tetraimine |
0.009 |
Up |
CYP2A6 |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.023 |
Up |
CYP2A6 |
1-Naphthalenecarboxamide, N,N'-1,8-(octanediyl)bis- |
0.003 |
Up |
CYP2A6 |
4,8-Ethenobenzo[1,2-c:4,5-c']dipyrrole-1,3,5,7-tetrone, 2,6-bis(3-cyanophenyl)-1,2,3,3a,4,4a,5,6,7,7a,8,8a- dodecahydro- |
0.001 |
Up |
CYP2A6 |
NSC 634398 |
0.002 |
Up |
CYP2A6 |
Oxalic acid, mono(4,9-dihydro-4,9-dioxonaphtho[2,3-d] thiazol-2-yl)hydrazide, monoethyl ester |
0.021 |
Up |
CYP2A6 |
2-Propen-1-one, 1-(4-chlorophenyl)-3-[4-[2-oxo- 2-(4-phenyl-1-piperazinyl)ethoxy]phenyl]-, (E)- |
0.015 |
Up |
CYP2A6 |
3-Furancarbothioamide, [[3-(2-butenoxy)-4-methoxyphenyl]- 2-methyl- |
0.004 |
Up |
Expression pattern: Sensitivity / Resistance
Total:11 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:24
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|